Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Articles

Protecting New Investments in Old Drugs

March 31, 2009

Articles

Protecting New Investments in Old Drugs

March 31, 2009

Back to News Listing

FDLI Update Magazine, 2009, Issue 2

By: Terry G. Mahn
In an earlier article, the author discussed the shift taking place since the 2003 Orange Book reforms with pioneer drug companies looking for new ways to protect old drugs. A creative approach followed by some pioneers has been to patent new drug features that would appear on drug labels in the form of patent protected language that generic manufacturers are then either forced to infringe, await expiration or seek Food and Drug Administration (FDA) permission to “carve out.”
Related Attorneys

Stay current with Fish Sign up for our Newsletter